Secondhand exposure to aerosol from electronic cigarettes: pilot study of assessment of tobacco-specific nitrosamine (NNAL) in urine

This project was co-funded by the Instituto de Salud Carlos III, Subdirección General de Evaluación, Government of Spain (PI12/01114, PI12/01119, PI15/00291, PI15/00434) co-funded by ISCIII-Subdirección General de Evaluación and by FEDER funds/European Regional Development Fund (ERDF) — a way to bui...

Descripción completa

Detalles Bibliográficos
Autores: Martínez-Sánchez, Jose M., Ballbè, Montse, Pérez-Ortiño, Raúl, Fu, Marcela, Sureda, Xisca, Pascual, José A., Peruga, Armando, Fernández, Esteve
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:20.500.12328/2999
Acceso en línea:http://hdl.handle.net/20.500.12328/2999
https://dx.doi.org/10.1016/j.gaceta.2018.07.016
Access Level:acceso abierto
Palabra clave:Biomarcadors
Nitrosamines
Aerosol de segona mà
Cigarreta electrònica
Biomarcadores
Nitrosaminas
Aerosol de segunda mano
Cigarrillo electrónico
Biomarkers
Second-hand aerosol
Electronic cigarette
61
616.2
616.6
Descripción
Sumario:This project was co-funded by the Instituto de Salud Carlos III, Subdirección General de Evaluación, Government of Spain (PI12/01114, PI12/01119, PI15/00291, PI15/00434) co-funded by ISCIII-Subdirección General de Evaluación and by FEDER funds/European Regional Development Fund (ERDF) — a way to build Europe —. J.M. Martínez-Sánchez is supported by the Ministry of Universities and Research, Government of Catalonia (grant 2017SGR608). M. Fu, M. Ballbè and E. Fernández are supported by the Ministry of Universities and Research, Government of Catalonia (2017SGR139). J.A. Pascual and R. Pérez Ortuno˜ are supported by the Ministry of Universities and Research, Government of Catalonia (grant 2017SGR138). E. Fernández is supported by the Instituto de Salud Carlos III, Government of Spain (INT16/00211 and INT17/00103), co-funded by the European Regional Development Fund (FEDER).